128
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Outcome of Off-Label AREDS 2 Supplementation for the Treatment of Macular Degeneration in Non-Proliferative Idiopathic Type 2 Macular Telangiectasia

, , , , , , , & show all
Pages 1133-1143 | Published online: 15 Mar 2021